Digital therapeutics company HealthBeacon has announced a new commercial partnership with the American Pharmacists Association Foundation.
The Dublin headquartered firm develops products for managing injectable medications for people in the home.
It said the new deal will enable patients to access enhanced medication use support through an integrated pharmacist offering with the HealthBeacon Injection Care Management System (ICMS) products in community pharmacies across the US.
Healthbeacon said the partnership will enable pharmacies to offer its technology to patients on injectable medications.
This will support the company's goal of achieving 100,000 patients using the its technology by the first quarter of 2024, it added.
The APhA Foundation is an affiliated non-profit of the American Pharmacists Association, the oldest, largest, national professional association of pharmacists in the US.
Jim Joyce, HealthBeacon CEO, said the community pharmacy setting is an excellent location for patients to access innovative pharmacist delivered medication adherence support and tools.
"Today half of all patients fail to utilise their medications as prescribed, costing healthcare systems billions of avoidable costs and the patients their underlying health," Mr Joyce said.
"Together we have developed a best-in-class tech and service offering to address this challenge and we are delighted to be working the APhA Foundation to make this a reality. We believe this is a positive step in making our technology more accessible to patients across the United States and that it will provide us with a model to deploy in other markets in the future," he added.
